Recently, successful malaria-control interventions are challenged by the spread of (i) insecticide resistance [8, 9], (ii) HRP2/3 deletions in the parasite’s genome [10, 11], which cause false-negative RDT results, and (iii) drug resistance. Here, HDGFL2 is linked to malaria.